A recent clinical review and editorial synthesized in The Journal of Obstetrics and Gynecology of India in August 2026 ...

Helix, the leading enterprise genomics platform, today announced the availability of Whole Exome+® Sequencing (WES+), a comprehensive diagnostic sequencing test now available to ordering providers ...

Bionano Laboratories has validated its OGM-Dx HemeOne diagnostic test for hematologic malignancy analysis. The test is expected to be eligible for coverage under the proposed LCD once the policy is ...

New York State Department of Health approval allows clinical use of optical genome mapping (OGM) based lab developed tests ...

An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from ...

The draft LCD would provide coverage for genome-wide assays that detect copy number alterations and structural variants when testing informs diagnosis or clinical management in accordance with current ...

Follow-up testing after atypical cell-free DNA (cfDNA) screening, sometimes used in FNAIT assessment, may identify genetic ...

Whole Exome+ Sequencing integrates exome, mitochondrial, and digital karyotype analysis, aiming to reduce standalone CMA ...

Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and ...

GOLDEN — A Jefferson County judge sentenced former Colorado Bureau of Investigation scientist Yvonne “Missy” Woods to 10 ...

Multiparametric flow cytometry—a test that is widely accessible, cost-effective and timely—can find one cancerous cell hidden ...